SCHEMBL8798252

SCHEMBL8798252

CCOC(=O)C(CCCNC(=O)OC(C)(C)C)(OCCc1cccnc1)C(=O)OCC

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 6/20 0.56
FAAH O00519 1/20 0.43
NAMPT P43490 1/20 0.41
CHRNA7 P36544 1/20 0.41
IDO1 P14902 2/20 0.40
PTAFR P25105 1/20 0.40
TBXAS1 P24557 4/20 0.40
PTPRB P23467 1/20 0.39
HDAC3 O15379 1/20 0.39
HDAC4 P56524 1/20 0.39
HDAC1 Q13547 1/20 0.39
HDAC7 Q8WUI4 1/20 0.39
HDAC2 Q92769 1/20 0.39
HDAC10 Q969S8 1/20 0.39
HDAC11 Q96DB2 1/20 0.39
HDAC8 Q9BY41 1/20 0.39
HDAC6 Q9UBN7 1/20 0.39
HDAC9 Q9UKV0 1/20 0.39
HDAC5 Q9UQL6 1/20 0.39
NCOR2 Q9Y618 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8798754 0.91 CYP3A4 (0.57) CYP3A4FAAHNAMPTIDO1PTPRB
SCHEMBL8803281 0.88 HDAC3 (0.51) CYP3A4IDO1PTPRBHDAC3HDAC4
SCHEMBL8799637 0.83 CYP3A4 (0.49) CYP3A4FAAHNAMPTIDO1PTPRB
SCHEMBL8799056 0.83 SIGMAR1 (0.51) CYP3A4IDO1PTPRBHDAC3HDAC4
SCHEMBL8798836 0.82 CYP3A4 (0.56) CYP3A4FAAHNAMPTIDO1PTPRB
SCHEMBL29357760 0.81 CYP3A4 (0.69) CYP3A4FAAHNAMPTCHRNA7PTAFR
SCHEMBL4603002 0.81 CYP3A4 (0.69) CYP3A4FAAHNAMPTCHRNA7PTAFR
SCHEMBL8799761 0.81 CYP3A4 (0.44) CYP3A4NAMPTIDO1PTPRB
SCHEMBL8329540 0.81 IDO1 (0.50) CYP3A4IDO1PTPRBHDAC3HDAC4
SCHEMBL8798249 0.80 CYP3A4 (0.46) CYP3A4FAAHNAMPTIDO1PTPRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0792878-A2 Geminal carboxylic acids and esters thereof, pharmaceutical formulations containing them useful in the treatment of bone dysmetabolism Dompé S.P.A. (IT) 1997-09-03 EP disclosed